Hinge Health Inc(HNGE) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 5:26 PM ET (Korea 9/12 06:26)
Full metrics table
| Index | RUT | P/E | 68.22 | EPS (ttm) | 1.3 | Insider Own | 35.92% | Shs Outstand | 60.9M | Perf Week | -2.39% |
| Market Cap | 7.15B | Forward P/E | 30.28 | EPS next Y | 26.15% | Insider Trans | -12.3% | Shs Float | 51.7M | Perf Month | 2.63% |
| Enterprise Value | 6.77B | PEG | 1.57 | EPS next Q | 0.6 | Inst Own | 67.29% | Short Float | 10.52% | Perf Quarter | 36.82% |
| Income | 0.11B | P/S | 9.93 | EPS this Y | -11.49% | Inst Trans | 14.27% | Short Ratio | 2.77 | Perf Half Y | 99.26% |
| Sales | 0.72B | P/B | 20.63 | EPS next 5Y | 19.29% | ROA | 13.98% | Short Interest | 5.44M | Perf YTD | 90.72% |
| Book/sh | 4.29 | P/C | 18.36 | EPS past 3/5Y | -96.58% - | ROE | 29.63% | 52W High | -7.3% ($95.57) | Perf Year | 47.7% |
| Cash/sh | 4.83 | P/FCF | 25.18 | Sales past 3/5Y | 41.71% - | ROIC | 30.74% | 52W Low | 194.51% ($30.08) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | 66.38 | EPS Y/Y TTM | 124.68% | Gross Margin | 84.49% | Volatility(W/M) | 4.74% 4.86% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 9.4 | Sales Y/Y TTM | 49.76% | Oper. Margin | 13.5% | ATR (14) | 4.47 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.16 | EPS Q/Q | 107.01% | Profit Margin | 14.77% | RSI (14) | 50.85 | Recom | 1.25 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.25 | Sales Q/Q | 53% | SMA20 | -1.35% ($89.8) | Beta | 1.49 | Target Price | $107.73 |
| Payout | - | Debt/Eq | 0.02 | Earnings | 2026/8/4 | SMA50 | 2.98% ($86.03) | Rel Volume | 0.88 | Prev Close | $88.26 |
| Employees | 143 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -4.07% 5.64% | SMA200 | 53.5% ($57.71) | Avg Volume(3M) | 1.96M | Price | $88.59 |
| IPO | 2025/5/22 | Option/Short | Yes/Yes | Trades | 18353 | Volume | 1,720,488 | Change | 0.37% |
Company
HNGE is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🦵 This healthcare company operates a digital musculoskeletal care platform. It offers subscription-based treatment and prevention programs for joint and muscle pain, targeting self-insured employers and health insurance companies, with a care model that combines artificial intelligence and remote physical therapy at its core. More recently, it has expanded into hybrid care by adding an in-person provider network.
Over the past 1 year, on the higher side
7% below its 1-year high.
HNGE makes money exceptionally well
13.5% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by -11.5% this year.
Tap to view numbers
The price looks about right
Trading at 68.2 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership is about average
Institutions hold 67.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
XHS 0.02%
HEAL 0.02%
BCTK 0.02%
EKG 0.01%
HYP 0.01%It ranks #4 in the industry
Based on market cap of $7B.
HNGE $7B PER 68.2
VEEV $42B PER 43.2
BTSG $12B PER 43.9
TEM $11B PER -
FAQ
What kind of company is HNGE?
HNGE belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of HNGE?
The market cap of HNGE is approximately $7.1B, ranking 1,136 within its sector.
What is the P/E ratio of HNGE?
HNGE has a P/E ratio of approximately 68.2x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for HNGE?
HNGE has recorded a 52-week high of $95.57 and a low of $30.08.
